Peripheral blood progenitor cell transplantation.

@article{Jansen2002PeripheralBP,
  title={Peripheral blood progenitor cell transplantation.},
  author={Jan Jansen and James M. Thompson and Michael J. Dugan and Pamela L Nolan and Michael C. Wiemann and Ruemu E. Birhiray and P. Jean Henslee-Downey and Luke P. Akard},
  journal={Therapeutic apheresis : official journal of the International Society for Apheresis and the Japanese Society for Apheresis},
  year={2002},
  volume={6 1},
  pages={
          5-14
        }
}
Peripheral blood progenitor cells (PBPCs) have become increasingly popular over the last 15 years as the source of hematopoietic stem cells for transplantation. In the early 1990s, PBPCs replaced bone marrow (BM) as the preferred source of autologous stem cells, and recently the same phenomenon is seen in the allogeneic setting. Under steady-state conditions, the concentration of PBPCs (as defined by CFU-GM and/or CD34+ cells) is very low, and techniques were developed to increase markedly this… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 24 CITATIONS

High-dose therapy and autologous peripheral blood stem cell transplantation in patients with multiple myeloma.

  • Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer
  • 2011
VIEW 1 EXCERPT
CITES BACKGROUND
HIGHLY INFLUENCED